Munich CyberKnife Center: Pioneer in offering most advanced tumor treatment

Press Releases

First ten cancer treatments successfully performed with the CyberKnife® M6™ System using the new InCise™ 2 Multileaf Collimator

Munich, October 1st, 2015 - The European CyberKnife Center Munich (ECZM) announced today that they have successfully performed their first ten treatments with the CyberKnife® M6™ System using the new InCise™ 2 Multileaf Collimator (MLC). Recently developed and officially released for clinical usage, the MLC expands the versatility of the CyberKnife System, enabling clinicians to treat a broader range of tumors in size and shape than before with significantly reduced treatment times. With the adoption of the new InCise 2 MLC, the Munich CyberKnife Center continues to provide its patients with cutting-edge treatments.

Contact us for questions about your Cyberknife treatment

Direct contact
to Cyberknife

  • Call in

  • Contact sheet

Your direct contact to
Cyberknife

+49 89 45 23 36 -0

  1. contact sheet
    1. Data transmission

      If you want to send us your images or reports online,
      request a login to our data upload here:

European Cyberknife Center Munich
Max Lebsche Platz 31
D - 81377 Munich, Germany

+49-89-452336-0

Contact us

Imprint  |  Privacy policy